Haemonetics Corporation
103.16USD
+0.3200 (+0.31%)
Fetching financial statements from SEC filings…
| In $M except per-share | Q1 FY27 | Q4 FY26* | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25* | Q3 FY25 | Q2 FY25 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 339 | 346 | 339 | 327 | 321 | 331 | 349 | 346 |
| Cost of Revenue | 137 | 148 | 137 | 133 | 129 | 138 | 155 | 158 |
| Gross Profit | 203 | 198 | 202 | 195 | 192 | 193 | 194 | 187 |
| Operating Income | 57 | -23 | 67 | 58 | 54 | 71 | 59 | 52 |
| Net Income | 33 | -20 | 45 | 39 | 34 | 58 | 37 | 34 |
| EPS (Diluted) | $0.72 | $-0.41 | $0.95 | $0.81 | $0.70 | $1.17 | $0.74 | $0.66 |
* Derived period (computed from FY minus reported quarters). Source: SEC filings (EDGAR)